The successes of novel therapies and molecular testing in lung cancer and patient access
Early clinical trials of immunotherapy treatment combinations
Clinical implications of CTCs in prostate cancer – are they the best thing to measure?
Current developments in castration-resistant prostate cancer therapies
Abstracts presented at ASCO 2017: drug re-challenge and pharmacoeconomics